Innovating Works

CROMA

Desconocido
ALEXANDER: Mucus Permeating Nanoparticulate Drug Delivery Systems CROMA-PHARMA GMBH participó en un FP7: The objective of the ALEXANDER project is the identification of novel strategies (e.g., proteolytic enzyme strategy, thiomer strategy, zeta...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.